Day One Biopharmaceuticals (DAWN)
US Market

Day One Biopharmaceuticals Balance Sheet


Day One Biopharmaceuticals Balance Sheet

Day One Biopharmaceuticals's total assets for Q3 2022 were $381.86M, a decrease of -5.49% from the previous quarter. DAWN total liabilities were $18.79M for the fiscal quarter, a 40.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 21Dec 20Dec 19
Total Assets
$ 289.82M$ 45.66M$ 27.34M
Total Liabilities
$ 8.67M$ 94.16M$ 32.52M
Total Equity Gross Minority
$ 281.15M$ -48.50M$ -5.19M
Total Capitalization
$ 281.15M$ -48.50M$ -5.19M
Preferred Stock Equity
-$ 5.70M$ 5.49M
Capital Lease Obligations
$ 220.00K$ 402.00K$ 0.00
Currency in USD

Day One Biopharmaceuticals Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis